PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs

Proprotein convertase subtilisin kexin type 9 (PCSK9) is a key regulator of low-density lipoprotein (LDL) cholesterol metabolism and the target of lipid-lowering drugs. PCSK9 is mainly expressed in hepatocytes. Here, we show that PCSK9 is highly expressed in undifferentiated human induced pluripoten...

Descripción completa

Detalles Bibliográficos
Autores principales: Roudaut, Meryl, Idriss, Salam, Caillaud, Amandine, Girardeau, Aurore, Rimbert, Antoine, Champon, Benoite, David, Amandine, Lévêque, Antoine, Arnaud, Lucie, Pichelin, Matthieu, Prieur, Xavier, Prat, Annik, Seidah, Nabil G., Zibara, Kazem, Le May, Cedric, Cariou, Bertrand, Si-Tayeb, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693623/
https://www.ncbi.nlm.nih.gov/pubmed/34739847
http://dx.doi.org/10.1016/j.stemcr.2021.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693623/
https://www.ncbi.nlm.nih.gov/pubmed/34739847
http://dx.doi.org/10.1016/j.stemcr.2021.10.004

Ejemplares similares